Reports Q4 revenue $5.34B, consensus $5.31B. “2025 was a defining year for our Company, with exceptional performance across all our operating segments and a reduction in cost and capital expenditures that surpassed our targets. Alongside delivering structural free cash flow growth, we took decisive actions to optimize our portfolio, strengthen our balance sheet and increase cash returns to shareholders,” commented Ken Seitz, Nutrien’s (NTR) president and CEO.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTR:
- Nutrien announces normal course issuer bid to purchase up to 5% of shares
- Nutrien increases quarterly dividend 1% to 55c per share
- Nutrien price target raised to $70 from $64 at Barclays
- Nutrien price target raised to $80 from $72 at TD Securities
- Options Volatility and Implied Earnings Moves This Week, February 16 – February 19, 2026
